What’s CH.1.1? Meet ‘Orthrus,’ a new wildcard Omicron strain with a concerning Delta mutation
— Jess (@MeetJess) January 28, 2023
There's now a new player being that could give Kraken a run for its money. CH.1.1, or “Orthrus,” was estimated to comprise 1.5% of U.S. cases as of Friday. https://t.co/zG7lnRPktO
“Disruption of the blood-brain barrier due to long COVID” /🧵 #LongCovid #notrecovered https://t.co/YHvnJ2BQ2W
— Junior (@42soho) January 27, 2023
“‘These are people who never had cholesterol problems before,’ said Dr. Ziyad Al-Aly, an author of the study… ‘Now, all of a sudden, they started having problems weeks and months after Covid-19.’” https://t.co/5jEhBf0euq
— Laura Miers (@LauraMiers) January 27, 2023
“But we now have plenty of evidence suggesting that exposure does not strengthen our immune system, but may weaken it. The virus attacks & depletes immune cells…We also know that, with every new exposure, we are more likely to suffer adverse effects.” https://t.co/7mfgMGLFv4 pic.twitter.com/ZdCOHIS1X1
— Laura Miers (@LauraMiers) January 26, 2023
“We’re very early,' @PutrinoLab says.. But every sample from #LongCovid patients has revealed #MicroClots."
— charlos (@loscharlos) January 26, 2023
"They are not capable of clogging large vessels.. but they can significantly affect organ function."https://t.co/S5QURASCKK
No comments:
Post a Comment